Evidence map›Paper›PMID 36635482›Full record

ArticleCardiovascular research2023

STRA6 is essential for induction of vascular smooth muscle lineages in human embryonic cardiac outflow tract development.

Chikai Zhou, Timm Häneke, Eduarde Rohner, Jesper Sohlmér, Polina Kameneva, Artem Artemov, Igor Adameyko, Makoto Sahara

Open access · hybridAbstract read
In one paragraph

Article in Cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. In-Depth Genomic Analysis: The New Challenge in Congenital Heart Disease.International journal of molecular sciences · 2024
    Review
  7. ZNF714 Supports Pro-Oncogenic Features in Lung Cancer Cells.International journal of molecular sciences · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Chikai ZhouDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Timm HänekeDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Eduarde RohnerDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Jesper SohlmérDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Polina KamenevaDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Artem ArtemovDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Igor AdameykoDepartment of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
Makoto SaharaDepartment of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0002-6281-5454
Karolinska Institutet · SEMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsRetinoic acid (RA) signalling is essential for heart development, and dysregulation of the RA signalling can cause several types of cardiac outflow tract (OFT) defects, the most frequent congenital heart disease (CHD) in humans. Matthew-Wood syndrome is caused by inactivating mutations of a transmembrane protein gene STRA6 that transports vitamin A (retinol) from extracellular into intracellular spaces. This syndrome shows a broad spectrum of malformations including CHD, although murine Stra6-null neonates did not exhibit overt heart defects. Thus, the detailed mechanisms by which STRA6 mutations could lead to cardiac malformations in humans remain unclear. Here, we investigated the role of STRA6 in the context of human cardiogenesis and CHD. METHODS AND

resultsTo gain molecular signatures in species-specific cardiac development, we first compared single-cell RNA sequencing (RNA-seq) datasets, uniquely obtained from human and murine embryonic hearts. We found that while STRA6 mRNA was much less frequently expressed in murine embryonic heart cells derived from the Mesp1+ lineage tracing mice (Mesp1Cre/+; Rosa26tdTomato), it was expressed predominantly in the OFT region-specific heart progenitors in human developing hearts. Next, we revealed that STRA6-knockout human embryonic stem cells (hESCs) could differentiate into cardiomyocytes similarly to wild-type hESCs, but could not differentiate properly into mesodermal nor neural crest cell-derived smooth muscle cells (SMCs) in vitro. This is supported by the population RNA-seq data showing down-regulation of the SMC-related genes in the STRA6-knockout hESC-derived cells. Further, through machinery assays, we identified the previously unrecognized interaction between RA nuclear receptors RARα/RXRα and TBX1, an OFT-specific cardiogenic transcription factor, which would likely act downstream to STRA6-mediated RA signalling in human cardiogenesis.

conclusionOur study highlights the critical role of human-specific STRA6 progenitors for proper induction of vascular SMCs that is essential for normal OFT formation. Thus, these results shed light on novel and human-specific CHD mechanisms, driven by STRA6 mutations.

Indexed as

Heart Defects, CongenitalMuscle, Smooth, VascularAnimalsGene Expression RegulationHeartHumansMembrane ProteinsMiceTretinoinVitamin AMembrane ProteinsSTRA6 protein, humanStra6 protein, mouseTretinoinVitamin ACardiac outflow tractCongenital heart diseaseHeart developmentMatthew-Wood syndromeRetinoic acidSingle-cell RNA-seqSmooth muscle cell

Identifiers

PMID36635482
PMCPMC10202647
OpenAlexW4315776870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.